Drug
PF-06291874 clinical trials
Also written PF-06291874.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2013
How studies write it
Studies that test it under each name
Development codes
- PF-06291874
- 4
Studies by the year they started
4 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses PF-06291874 is read from its arms, and is right about nine times in ten.
Testing it · 4
- PF-06291874 Multiple Ascending Dose Study In Type 2 Diabetes Mellitus PatientsCompletedPhase 1PfizerNCT01856595Written as PF-06291874
- A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On MetforminCompletedPhase 2PfizerNCT02554877Written as PF-06291874
- Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes MellitusCompletedPhase 2PfizerNCT02175121Written as PF-06291874
- Single Dose Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 In Healthy Adult SubjectsCompletedPhase 1PfizerNCT01794364Written as PF-06291874